As one of key nuclear matrix‐associated proteins (NMPs), SATB2 has been reported to regulate expression of certain genes during development and cancer progression, but the role of SATB2 in glioma stem cells and GBM malignant growth has not been defined. The gene discussed is SATB2; the disease is central nervous system cancer.